6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	United Maritime Reports Improved First Quarter 2026 Financial Results and Declares Quarterly Cash Dividend of $0.10 Per Share
Just now	Data I/O to Present at the Planet MicroCap Investor Conference Powered by MicroCapClub
1m ago	Rapid7 Q1 2026 Threat Landscape Report Finds Vulnerability Exploitation Overtakes Social Engineering as the Top Initial Access Vector
1m ago	Jamal Satli Iglesias, Marriott International and Aimbridge Hospitality Announce Landmark All-Inclusive Resort in Riviera Maya
1m ago	Chevron Introduces Next-gen Techron in U.S. Chevron and Texaco Gasolines

About

68.98USD+0.25 +0.36%

Closed • Updated at 13:36 GMT+00:00

Market Cap$8.18B

P/E Ratio24.81

Volume1.43M

Beta0.54

RSI56.79

Gross Margin76.93%

Health TechnologyBiotechnology

Halozyme Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE

Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets

Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology

Halozyme to Report First Quarter 2026 Financial and Operating Results

Halozyme Appoints Darren Snellgrove as Chief Financial Officer

Community Chat

Ask AI